If the company keeps on failing to impress, it can go below 10c. But I have a gut feeling that it may be able to the corner for FY17.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025